IDO1 and neoplasm: Thaker et al. found that IDO1 directly promotes tumour growth and tumour epithelial proliferation in a cell-independent manner through the synthesis of uric acid metabolites and activation of β-catenin signalling, showing that IDO1 can be a potential therapeutic target (Thaker et al., 2013).